 | | Vol. 12.07 – 21 February, 2024 |
| |
|
|
| Scientists performed a genome-wide CRISPR-Cas9 activation library screening and found that Asialoglycoprotein receptor 1 promoted SARS-CoV-2 pseudovirus infection of HeLa cells.
[Signal Transduction And Targeted Therapy] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
| |
|
|
| Human small airway epithelial cells were exposed to the SARS-CoV-2 spike protein receptor binding domain and transcriptional mechanisms were investigated.
[Signal Transduction And Targeted Therapy] |
|
|
|
| Researchers performed intranasal inoculation of 34 young adult, seronegative volunteers with a pre-Alpha SARS-CoV-2 strain.
[Science Immunology] |
|
|
|
| Researchers highlighted that open reading frame 7a (ORF7a) could be a therapeutic target, and glecaprevir may hold potential as a drug against SARS-CoV-2 by targeting ORF7a.
[Autophagy] |
| | MORE IMMUNOLOGY OF INFECTIOUS DISEASE |
|
|
|
| Scientists investigated the associations of HIV and HIV-specific factors with cardiac magnetic resonance phenotypes in female participants enrolled in the Women’s Interagency HIV Study’s New York and San Francisco sites.
[Clinical Infectious Diseases] |
|
|
|
| Investigators demonstrated that tumor necrosis factor signaling in monocytes is required for bacterial containment following enteric Yersinia infection.
[Journal Of Experimental Medicine] |
|
|
|
| Six people with HIV (PWH) received infusions of 2 × 107 HIV-specific T cells (HXTCs)/m² with vorinostat (VOR) 400 mg, and 3 PWH received infusions of 10 × 107 HXTCs/m² with VOR. The frequency of persistent HIV by multiple assays was measured before and after study therapy.
[Journal Of Infectious Diseases] |
|
|
|
| Investigators constructed a T-cell epitope-rich tripeptide-splicing fragment of Rv2201 from the Mycobacterium tuberculosis genome, ultimately yielding the recombinant protein Rv2201-519 in Escherichia coli BL21.
[International Immunopharmacology] |
|
|
|
| Researchers provided strong evidence of a protective role for a combined mother–infant low CD4+ T-cell CCR5 density phenotype in in-utero transmission/acquisition of HIV-1.
[Aids] |
|
|
|
|
| The authors summarize many of the currently licensed influenza vaccines available across the world and current vaccines in clinical trials. They then briefly discuss the important role of CD8+ T cells during influenza infection and why future influenza vaccines should consider targeting CD8+ T cells.
[Clinical & Translational Immunology] |
|
|
|
|
| The COVID-19 pandemic saw an explosion in publication of preprint articles, many by authors who had never produced one before. Now it seems a high proportion of these scientists are likely to continue the practice.
[Nature] |
|
|
|
|
| March 13 – 16, 2024
Davos, Switzerland |
|
|
|
|
|
| | King’s College London – London, England, United Kingdom |
|
|
|
| | Queen’s University Belfast – Belfast, Ireland, United Kingdom |
|
|
|
| | University of Alberta – Edmonton, Alberta, Canada |
|
|
|
| | UC Davis – Davis, California, United States |
|
|
|
| | Umeå University – Umeå, Sweden |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
